These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 4893821

  • 21. Children immunized with HPV-77 rubella vaccine. Additional laboratory observations.
    Katz SL, Lang DJ, Wilfert CM, Feigin RD, Goldfein M.
    Am J Dis Child; 1969 Aug; 118(2):213-7. PubMed ID: 4893822
    [No Abstract] [Full Text] [Related]

  • 22. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)].
    Rocchi G, Salvadori A.
    Nuovi Ann Ig Microbiol; 1970 Aug; 21(4):336-40. PubMed ID: 5518412
    [No Abstract] [Full Text] [Related]

  • 23. Comparative studies of rubella vaccines.
    Karchmer AW, Herrmann KL, Friedman JP, Shope TC, Page EE, Dressler MS, Armes WH, Witte JJ.
    Am J Dis Child; 1969 Aug; 118(2):197-202. PubMed ID: 5794814
    [No Abstract] [Full Text] [Related]

  • 24. Field trial of live attenuated rubella virus vaccine during an epidemic on Taiwan. Preliminary report of efficacy of three HPV-77 strain vaccines in the prevention of clinical rubella.
    Grayston JT, Detels R, Chen KP, Gutman L, Kim KS, Gale JL, Beasley RP.
    JAMA; 1969 Feb 10; 207(6):1107-10. PubMed ID: 4884671
    [No Abstract] [Full Text] [Related]

  • 25. [Results of a trial of anti-rubella vaccination with vaccine made up of the "Cendehill-51" live and attenuated virus strain].
    Portolani M, Rondinini B, Brighi W, Maccolini E.
    Minerva Med; 1970 Apr 14; 61(30 Suppl):1590-4. PubMed ID: 5439724
    [No Abstract] [Full Text] [Related]

  • 26. Clinical trial of live attenuated rubella virus vaccine, HPV-77 strain.
    Cooper LZ, Giles JP, Krugman S.
    Am J Dis Child; 1968 Jun 14; 115(6):655-7. PubMed ID: 4968322
    [No Abstract] [Full Text] [Related]

  • 27. Attenuated rubella virus vaccine in women. Clinical trials during the postpartum period.
    Boué A, Papiernick-Berkhauer E, Lévy-Thierry S.
    Am J Dis Child; 1969 Aug 14; 118(2):230-3. PubMed ID: 4893823
    [No Abstract] [Full Text] [Related]

  • 28. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM, Parkman PD, Hobbins TE, Larson HE, Davis WJ, Simsarian JP, Hopps HE.
    Am J Dis Child; 1969 Aug 14; 118(2):155-65. PubMed ID: 4978508
    [No Abstract] [Full Text] [Related]

  • 29. [Clinical test of an anti-rubella vaccine on a group of children belonging to a closed community].
    Gasparini V, Trivello R, Diana L, Romano M, Drago E, Rausa G.
    Minerva Med; 1970 Apr 14; 61(30 Suppl):1583-9. PubMed ID: 5439723
    [No Abstract] [Full Text] [Related]

  • 30. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus].
    Fara GM, Galli MG, Nodari R, Saccani CF, Marangoni L, Bozzetti A, Tarantino F.
    Minerva Med; 1970 Apr 14; 61(30 Suppl):1574-7. PubMed ID: 5439721
    [No Abstract] [Full Text] [Related]

  • 31. Experimental active and passive immunization against rubella.
    Budai J, Tóth M, Melis L.
    Acta Paediatr Acad Sci Hung; 1970 Apr 14; 11(3):209-17. PubMed ID: 4111953
    [No Abstract] [Full Text] [Related]

  • 32. Protective efficacy of duck embryo rubella vaccines.
    Stokes J, Weibel RE, Buynak EB, Hilleman MR.
    Pediatrics; 1969 Aug 14; 44(2):217-24. PubMed ID: 5817338
    [No Abstract] [Full Text] [Related]

  • 33. Clinical experience with Cendehill rubella vaccine in mature women.
    Farquhar JD, Corretjer JE.
    Am J Dis Child; 1969 Aug 14; 118(2):266-8. PubMed ID: 4893830
    [No Abstract] [Full Text] [Related]

  • 34. Rubella vaccination in adult females.
    Weibel RE, Stokes J, Buynak EB, Hilleman MR.
    N Engl J Med; 1969 Mar 27; 280(13):682-5. PubMed ID: 5250184
    [No Abstract] [Full Text] [Related]

  • 35. A study of rubella immunity and resistance to infection.
    Davis WJ, Larson HE, Simsarian JP, Parkman PD, Meyer HM.
    JAMA; 1971 Jan 25; 215(4):600-8. PubMed ID: 5107436
    [No Abstract] [Full Text] [Related]

  • 36. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR, Buynak EB, Whitman JE, Weibel RW, Stokes J.
    Am J Dis Child; 1969 Aug 25; 118(2):166-71. PubMed ID: 5815860
    [No Abstract] [Full Text] [Related]

  • 37. Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.
    Swartz TA, Klingberg W, Goldwasser RA, Klingberg MA, Goldblum N, Hilleman MR.
    Am J Epidemiol; 1971 Sep 25; 94(3):246-51. PubMed ID: 5093654
    [No Abstract] [Full Text] [Related]

  • 38. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine.
    Cooper LZ, Florman AL, Ziring PR, Krugman S.
    Am J Dis Child; 1971 Nov 25; 122(5):397-403. PubMed ID: 5129528
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K, Nategh R, Ahangary S, Mohsenin H.
    Am J Dis Child; 1970 Dec 25; 120(6):520-3. PubMed ID: 5481902
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.